000 01616 a2200397 4500
005 20250513201113.0
264 0 _c20000419
008 200004s 0 0 eng d
022 _a0387-5911
024 7 _a10.11150/kansenshogakuzasshi1970.73.1123
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOkada, J
245 0 0 _aEfficacy of sulfamethoxazole-trimethoprim administration in the prevention of Pneumocystis carinii pneumonia in patients with connective tissue disease.
_h[electronic resource]
260 _bKansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
_cNov 1999
300 _a1123-9 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAnti-Infective Agents
_xadministration & dosage
650 0 4 _aConnective Tissue Diseases
_xcomplications
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunocompromised Host
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPneumonia, Pneumocystis
_xprevention & control
650 0 4 _aPrednisolone
_xtherapeutic use
650 0 4 _aTrimethoprim, Sulfamethoxazole Drug Combination
_xadministration & dosage
700 1 _aKadoya, A
700 1 _aRana, M
700 1 _aIshikawa, A
700 1 _aIikuni, Y
700 1 _aKondo, H
773 0 _tKansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
_gvol. 73
_gno. 11
_gp. 1123-9
856 4 0 _uhttps://doi.org/10.11150/kansenshogakuzasshi1970.73.1123
_zAvailable from publisher's website
999 _c10579608
_d10579608